eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Covance Laboratories Inc. - Comment

Covance Laboratories Inc. - Comment

Document ID: FDA-2009-D-0539-0010
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: February 01 2010, at 04:27 PM Eastern Standard Time
Date Posted: February 2 2010, at 12:00 AM Eastern Standard Time
Comment Start Date: December 4 2009, at 12:00 AM Eastern Standard Time
Comment Due Date: February 2 2010, at 11:59 PM Eastern Standard Time
Tracking Number: 80a892e7
View Document:  View as format xml

View Comment

Dear Docket Manager: Enclosed please find comments from Covance, Immunochemistry in Chantilly, VA for the Draft Guidance for Assay Development for Immunogenicity Testing of Therapeutic Proteins dated December 2009. Sincerely Joseph Bower

Attachments:

Covance Laboratories Inc. - Comment

Title:
Covance Laboratories Inc. - Comment

View Attachment: View as format pdf

Related Comments

    View All
Total: 13
Novo Nordisk Inc. - Comment
Public Submission    Posted: 01/27/2010     ID: FDA-2009-D-0539-0004

Feb 02,2010 11:59 PM ET
MedImmune - Comment
Public Submission    Posted: 02/01/2010     ID: FDA-2009-D-0539-0005

Feb 02,2010 11:59 PM ET
Covance Laboratories Inc. - Comment
Public Submission    Posted: 02/02/2010     ID: FDA-2009-D-0539-0010

Feb 02,2010 11:59 PM ET
Amgen, Inc. - Comment
Public Submission    Posted: 02/02/2010     ID: FDA-2009-D-0539-0011

Feb 02,2010 11:59 PM ET
Facet Biotech - Comment
Public Submission    Posted: 02/02/2010     ID: FDA-2009-D-0539-0015

Feb 02,2010 11:59 PM ET